Ana S. Leal
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 4
-
- Retinoids in leukemia and cellular processes 11
- Natural product bioactivities and synthesis 9
- Protein Degradation and Inhibitors 5
- Pharmacology top 10%
-
- Pancreatic and Hepatic Oncology Research 4
-
- Estrogen and related hormone effects 4
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Co-authors
- Jorge A. R. SalvadorKaren T. LibyYongkui JingBruno M. F. GonçalvesVânia M. MoreiraMichael B. SpornRui WangDarlene B. Royce
- Partner nations
- United StatesPortugalFrance
In The Last Decade
Ana S. Leal
32 papers receiving 816 citations
Peers
Comparison fields: 5 of 78
- Toxicology 61
- Molecular Biology 655
- Pharmacology 49
- Complementary and alternative medicine 43
- Oncology 138
Countries citing papers authored by Ana S. Leal
This map shows the geographic impact of Ana S. Leal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana S. Leal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana S. Leal more than expected).
Fields of papers citing papers by Ana S. Leal
This network shows the impact of papers produced by Ana S. Leal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana S. Leal. The network helps show where Ana S. Leal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana S. Leal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 13 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 15 | |
| 7 | 2020 | 13 | |
| 8 | 2019 | 13 | |
| 9 | 2019 | 26 | |
| 10 | 2019 | 51 | |
| 11 | 2017 | 22 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 137 | |
| 14 | 2017 | 96 | |
| 15 | 2016 | 11 | |
| 16 | 2013 | 33 | |
| 17 | 2012 | 8 | |
| 18 | 2012 | 20 | |
| 19 | 2012 | 56 | |
| 20 | 2012 | 124 |
About Ana S. Leal
Ana S. Leal is a scholar working on Toxicology, Immunology and Molecular Biology, having authored 33 papers that have together received 826 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (11 papers), Natural product bioactivities and synthesis (9 papers), Protein Degradation and Inhibitors (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Estrogen and related hormone effects (4 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Toxicology (61 citations), Molecular Biology (655 citations) and Pharmacology (49 citations). Ana S. Leal has collaborated with scholars based in United States, Portugal and France. Frequent co-authors include Jorge A. R. Salvador, Karen T. Liby, Yongkui Jing, Bruno M. F. Gonçalves, Vânia M. Moreira, Michael B. Sporn, Rui Wang, Darlene B. Royce, Patricia A. Pioli and Sandra A. C. Figueiredo. Their work appears in journals such as Cancer Research, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.